MRI-guided radiation dose reduction for prostate cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older.
- You have prostate cancer that shows up on an MRI scan.
- Your cancer is at intermediate or high risk (not low risk).
- Your cancer has not spread outside the pelvis.
- You have not had prior treatment for prostate cancer (like surgery, radiation, hormone therapy, or chemotherapy).
- You are able to have an MRI (no metal implants, no severe claustrophobia, and good kidney function).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This trial tests a precise, short course of radiation therapy guided by MRI for men with low or favorable intermediate-risk prostate cancer. It aims to offer effective treatment with fewer sessions and fewer side effects.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This study tests radiation treatment planned and guided using MRI scans (“image-guided radiotherapy”) for men with prostate cancer who are aiming for a cure. If you qualify, you may receive radiation with more precise targeting using MRI to help deliver treatment accurately.
This study tests a higher dose of radiation for prostate cancer using an MRI-guided machine (MR-Linac). It aims to see if a more targeted dose can be safely given to the tumor while protecting healthy tissue.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.